n.abubakar
Submits third-party assay reports on material purchased directly. Based in Turku.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.15%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042191 | Ipamorelin | Homopeptide | HOMO-2608-A9045 | Medutest | 2026-Q3 | 99.67 | 5.00 | 104.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042691 | Sermorelin | GGPeps | GGPE-2508-U8736 | Janoshik | 2025-Q4 | 99.22 | 3.74 | 105.3 | Supplier-supplied | 0 | PASS |
| AX-2025-018926 | TB-500 | FGP | FGP-2508-S1106 | Janoshik | 2025-Q4 | 99.36 | 4.00 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020599 | Tirzepatide | SSA | SSA-2502-D7115 | VendorInvestigate | 2025-Q3 | 97.02 | 6.75 | 98.4 | Buyer-sourced | 2 | MARGINAL |
| AX-2024-005442 | Retatrutide | WXT | WXT-2407-A5417 | PeptideMeter | 2024-Q4 | 97.48 | 3.98 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2024-005111 | BPC-157 | KP | KP-2407-L4230 | Medutest | 2024-Q4 | 99.15 | 2.10 | 100.0 | Supplier-supplied | 1 | FAIL |
| AX-2024-004267 | Semaglutide | QYB | QYB-2311-U4777 | Janoshik | 2024-Q2 | 99.06 | 3.46 | — | Supplier-supplied | 1 | MARGINAL |